Complete Filing Data
BioAge Labs, Inc. reported Stockholders Equity of $272.05 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BioAge Labs, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | -$80.6M | -$71.1M | -$63.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$89.0K | $81.0K | -$3.0K |
| Research And Development Expense | $74.0M | $59.0M | $33.9M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$89.0K | $81.0K | -$3.0K |
| Operating Income Loss | -$92.8M | -$78.2M | -$48.4M |
| Operating Expenses | $101.8M | $78.2M | $48.4M |
| Nonoperating Income Expense | $12.2M | $7.1M | -$15.5M |
| Interest Expense Nonoperating | $697.0K | $2.4M | $7.8M |
| General And Administrative Expense | $27.8M | $19.2M | $14.5M |
| Comprehensive Income Net Of Tax | -$80.6M | -$71.0M | -$63.9M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $122.0K | $0.00 | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $33.0K | $81.0K | |
| Noncash Interest Expense | $163.0K | $1.0M | $6.5M |
| Revenue From Contract With Customer Excluding Assessed Tax | $9.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$20.2M | -$21.6M | -$12.9M | -$23.4M | -$13.6M | -$13.0M | -$14.6M | -$17.2M | -$11.1M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$10.0K | -$52.0K | -$10.0K | -$58.0K | -$18.0K | $21.0K | $35.0K | $47.0K | -$15.0K |
| Research And Development Expense | $18.5M | $19.8M | $11.1M | $20.0M | $10.5M | $9.3M | $6.5M | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$10.0K | -$52.0K | -$10.0K | $58.0K | -$18.0K | $21.0K | $35.0K | ||
| Operating Income Loss | -$23.1M | -$24.8M | -$16.4M | -$24.8M | -$15.3M | -$12.8M | -$9.9M | ||
| Operating Expenses | $25.2M | $27.2M | $17.9M | $24.8M | $15.3M | $12.8M | $9.9M | ||
| Nonoperating Income Expense | $3.0M | $3.2M | $3.5M | $1.3M | $1.7M | -$179.0K | -$4.7M | ||
| Interest Expense Nonoperating | $149.0K | $201.0K | $255.0K | $388.0K | $443.0K | $1.2M | $2.4M | ||
| General And Administrative Expense | $6.7M | $7.3M | $6.8M | $4.7M | $4.8M | $3.5M | $3.4M | ||
| Comprehensive Income Net Of Tax | -$20.1M | -$21.6M | -$12.9M | -$23.3M | -$13.6M | -$13.0M | -$14.6M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $73.0K | $0.00 | $29.0K | $0.00 | $0.00 | $0.00 | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $63.0K | -$52.0K | $19.0K | $58.0K | -$18.0K | $21.0K | |||
| Noncash Interest Expense | $117.0K | $876.0K | |||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $2.1M | $2.4M | $1.5M | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $272.1M | $323.1M | -$173.4M | -$112.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $188.9M | $354.3M | $25.0M | $27.6M |
| Gains Losses On Extinguishment Of Debt | $0.00 | -$250.0K | ||
| Cash And Cash Equivalents At Carrying Value | $188.9M | $354.3M | $21.6M | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $3.1M | $282.0K | $407.0K | |
| Retained Earnings Accumulated Deficit | -$333.4M | -$252.8M | -$181.7M | |
| Property Plant And Equipment Net | $963.0K | $591.0K | $323.0K | |
| Prepaid Expense And Other Assets Current | $4.9M | $2.8M | $349.0K | |
| Operating Lease Right Of Use Asset | $2.8M | $200.0K | $195.0K | |
| Operating Lease Liability Current | $582.0K | $202.0K | $194.0K | |
| Long Term Investments | $100.0K | $100.0K | $100.0K | |
| Long Term Debt Noncurrent | $0.00 | $2.5M | $8.2M | |
| Long Term Debt Current | $2.6M | $6.0M | $6.0M | |
| Liabilities Current | $20.1M | $27.8M | $58.2M | |
| Liabilities And Stockholders Equity | $294.9M | $358.2M | $25.9M | |
| Liabilities | $22.8M | $35.1M | $66.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$165.5M | $329.4M | -$2.7M | |
| Assets Current | $286.8M | $357.1M | $25.3M | |
| Assets | $294.9M | $358.2M | $25.9M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $278.0K | $245.0K | $164.0K | |
| Accrued Expenses And Other Current Liabilities | $8.5M | $11.8M | $7.9M | |
| Accounts Payable Current | $2.7M | $2.0M | $1.9M | |
| Repayments Of Debt | $6.0M | $6.0M | $1.0M | |
| Derivative Liabilities Noncurrent | $370.0K | $156.0K | $229.0K | |
| Other Assets Noncurrent | $216.0K | $240.0K | ||
| Contract With Customer Liability Noncurrent | $0.00 | $4.7M | ||
| Contract With Customer Liability Current | $5.8M | $7.8M | ||
| Noncash Lease Expense | $125.0K | $3.0K | ||
| Marketable Securities | $4.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $277.5M | $294.8M | $313.2M | $313.7M | -$197.1M | -$185.5M | -$153.1M | -$139.3M | -$122.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $215.6M | $220.3M | $257.5M | $334.5M | $159.1M | $177.3M | $34.5M | ||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$250.0K | |||
| Cash And Cash Equivalents At Carrying Value | $215.6M | $220.3M | $257.5M | $334.5M | $174.0M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $3.1M | $282.0K | |||||||
| Retained Earnings Accumulated Deficit | -$307.5M | -$287.3M | -$265.7M | -$231.7M | |||||
| Property Plant And Equipment Net | $973.0K | $974.0K | $929.0K | $543.0K | |||||
| Prepaid Expense And Other Assets Current | $4.5M | $3.8M | $3.9M | $2.0M | |||||
| Operating Lease Right Of Use Asset | $2.9M | $3.0M | $3.2M | $271.0K | |||||
| Operating Lease Liability Current | $580.0K | $630.0K | $700.0K | $273.0K | |||||
| Long Term Investments | $100.0K | $100.0K | $100.0K | $100.0K | |||||
| Long Term Debt Noncurrent | $0.00 | $0.00 | $1.1M | $3.9M | |||||
| Long Term Debt Current | $4.1M | $5.6M | $6.0M | $6.0M | |||||
| Liabilities Current | $24.5M | $22.8M | $23.7M | $19.1M | |||||
| Liabilities And Stockholders Equity | $305.1M | $322.1M | $343.8M | $337.4M | |||||
| Liabilities | $27.6M | $27.4M | $30.7M | $23.6M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$96.9M | $152.3M | |||||||
| Assets Current | $290.8M | $301.7M | $324.8M | $336.5M | |||||
| Assets | $305.1M | $322.1M | $343.8M | $337.4M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $275.0K | $212.0K | $264.0K | $109.0K | |||||
| Accrued Expenses And Other Current Liabilities | $7.3M | $7.6M | $4.9M | $10.7M | |||||
| Accounts Payable Current | $5.0M | $1.3M | $4.0M | $2.1M | |||||
| Repayments Of Debt | $1.5M | $1.5M | |||||||
| Derivative Liabilities Noncurrent | $150.0K | $108.0K | $97.0K | ||||||
| Other Assets Noncurrent | $227.0K | $237.0K | $239.0K | ||||||
| Contract With Customer Liability Noncurrent | $556.0K | $1.9M | $3.2M | ||||||
| Contract With Customer Liability Current | $7.5M | $7.7M | $8.2M | ||||||
| Noncash Lease Expense | $53.0K | $1.0K | |||||||
| Marketable Securities | $10.1M | $16.1M | $14.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $11.7M | $7.0M | $3.0M |
| Payments To Acquire Property Plant And Equipment | $719.0K | $366.0K | $166.0K |
| Net Cash Provided By Used In Operating Activities | -$81.6M | -$51.5M | -$37.4M |
| Net Cash Provided By Used In Investing Activities | -$95.2M | -$366.0K | -$266.0K |
| Net Cash Provided By Used In Financing Activities | $11.5M | $381.2M | $34.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.7M | $2.4M | -$37.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$3.4M | $4.6M | $3.7M |
| Increase Decrease In Accounts Payable | $788.0K | $6.0K | -$393.0K |
| Proceeds From Stock Options Exercised | $714.0K | $634.0K | $4.0K |
| Increase Decrease In Deferred Revenue | -$6.7M | $12.5M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$87.0K | $81.0K | |
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | $0.00 | $170.0M | |
| Payments Of Stock Issuance Costs | $0.00 | $542.0K | |
| Payments To Acquire Marketable Securities | $154.7M | $0.00 | |
| Increase Decrease In Other Current Assets | $240.0K | -$25.0K | |
| Increase Decrease In Accounts Receivable | $769.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Share Based Compensation | $2.9M | $852.0K |
| Payments To Acquire Property Plant And Equipment | $426.0K | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$17.4M | -$15.7M |
| Net Cash Provided By Used In Investing Activities | -$78.0M | $0.00 |
| Net Cash Provided By Used In Financing Activities | -$1.5M | $168.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.2M | $937.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$6.9M | -$4.1M |
| Increase Decrease In Accounts Payable | $2.0M | $361.0K |
| Proceeds From Stock Options Exercised | $0.00 | $3.0K |
| Increase Decrease In Deferred Revenue | -$1.1M | $0.00 |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$12.0K | $19.0K |
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | $0.00 | $170.0M |
| Payments Of Stock Issuance Costs | $0.00 | $502.0K |
| Payments To Acquire Marketable Securities | $77.6M | $0.00 |
| Increase Decrease In Other Current Assets | -$1.0K | $0.00 |
| Increase Decrease In Accounts Receivable | $361.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 35.9M | 10.7M | 1.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 35.9M | 10.7M | 1.7M |
| Earnings Per Share Diluted | $-2.24 | $-6.63 | $-38.17 |
| Earnings Per Share Basic | $-2.24 | $-6.63 | $-38.17 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 37.4M | 35.9M | 1.7M |
| Common Stock Shares Issued | 37.4M | 35.9M | 1.7M |
| Common Stock Shares Authorized | 500.0M | 500.0M | 52.4M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 35.9M | 35.9M | 35.9M | 3.5M | 1.7M | 1.7M | 1.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 35.9M | 35.9M | 35.9M | 3.5M | 1.7M | 1.7M | 1.7M |
| Earnings Per Share Diluted | $-0.56 | $-0.60 | $-0.36 | $-6.70 | $-7.94 | $-7.76 | $-8.74 |
| Earnings Per Share Basic | $-0.56 | $-0.60 | $-0.36 | $-6.70 | $-7.94 | $-7.76 | $-8.74 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 35.9M | 35.9M | 35.9M | 34.2M | |||
| Common Stock Shares Issued | 35.9M | 35.9M | 35.9M | 34.2M | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.7M | $7.0M | $3.0M |
| Interest And Other Income | $13.1M | $9.6M | $2.4M |
| Fair Value Adjustment Of Warrants | $214.0K | -$73.0K | $10.1M |
| Stock Issued During Period Value Stock Options Exercised | $714.0K | $634.0K | $4.0K |
| Interest Paid Net | $611.0K | $1.4M | $1.2M |
| Gain Loss From Changes In Fair Value Of Warrants | -$214.0K | $73.0K | |
| Depreciation Nonproduction | $213.0K | $167.0K | $162.0K |
| Additional Paid In Capital | $605.2M | $575.7M | $8.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.8M | $3.2M | $2.9M | $1.8M | $1.6M | $852.0K | $757.0K | $758.0K | $734.0K |
| Interest And Other Income | $3.2M | $3.4M | $3.7M | $2.0M | $2.2M | $1.3M | $499.0K | ||
| Fair Value Adjustment Of Warrants | -$59.0K | $306.0K | $8.0K | $2.8M | |||||
| Stock Issued During Period Value Stock Options Exercised | $184.0K | $422.0K | $3.0K | ||||||
| Interest Paid Net | $217.0K | $427.0K | |||||||
| Gain Loss From Changes In Fair Value Of Warrants | -$42.0K | -$11.0K | $59.0K | -$306.0K | -$70.0K | -$8.0K | |||
| Depreciation Nonproduction | $37.0K | $33.0K | |||||||
| Additional Paid In Capital | $584.7M | $581.9M | $578.6M | $545.3M |
Most recent annual filing with the SEC: March 24, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.